CClinicalTrials.gg
RecruitingNCT07538323WISE-DKUpdated Jun 30, 2026

Wrist Injury Strengthening Exercise (WISE) Versus Usual Care Advice for Improving Pain and Function

An interventional study of Supervised Exercise and Usual Care in Distal Radius Fracture, Colles Fracture and Wrist Fracture, sponsored by University of Aarhus. Recruiting at 1 site in Denmark. Open to participants aged 50 Years and older. Per ClinicalTrials.gov, last updated 2026-06-30.

Sponsored by University of Aarhus · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started May 2026; still recruiting 4 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
588
Allocation
Randomized
Ages
50 Years and older
Sex
All
01

Study summary

The goal of this clinical trial is to find out whether a therapist-guided exercise program helps people aged 50 and older recover better, in terms of pain and function, after a wrist fracture, compared to the usual care advice they would normally receive. The main question it aims to answer is:

  • Will participants who receive a therapist-supervised exercise program have better improvement in pain and function, as measured by the Patient Rated Wrist Evaluation questionnaire, six months after their injury?

Researchers will compare these participants with those who receive usual care, which includes advice on self-management, to see if the supervised exercise program leads to greater recovery.

Participants will:

  • Either receive supervised exercise, with a therapy session of up to 60 minutes and two additional sessions of up to 30 minutes each in addition to usual-care, or they will receive solely usual-care, consisting of advice on self-management.
  • Complete questionnaires electronically at baseline, 3-months, and 6-months.
02

Conditions studied

  • Distal Radius Fracture
  • Colles Fracture
  • Wrist Fracture
  • Wrist Fractures
  • Fracture Arm

Keywords

  • Exercise
  • Therapy
  • Resistance training
  • Strengthening exercise
03

In context

Wrist Fractures

323 studies on the registry are indexed under Wrist Fractures; 71 are open to participants now.

This study's planned enrollment of 588 is above the median of 64 across 261 interventional studies indexed under Wrist Fractures.

Browse Wrist Fractures studies →

Lead sponsor

University of Aarhus is the lead sponsor of 1,274 studies on the registry; 183 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Distal radius fracture treated surgically or non-surgically
  • Willing and able to give informed consent

Exclusion criteria

Exclusion Criteria:

  • Injury is more than two months old
  • There is evidence that the patient would be unable to participate in therapy or a self-guided exercise program provided by a participating center or adhere to study procedures (including cognitive impairment and fracture/surgery complications such as Complex Regional Pain Syndrome)
  • No e-mail address to receive electronic questionnaires
  • Open fractures with a Gustilo \& Anderson grading >1
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
588 participants (estimated)

Study arms

  • Experimental
    Supervised Exercise in addition to Usual Care (intervention)

    Other: Supervised Exercise · Other: Usual Care

  • Active comparator
    Usual Care

    Other: Usual Care

Interventions

  • OtherSupervised Exercise

    Verbal advice, a leaflet, and instruction in a strength training program delivered by an occupational or physical therapist at the hospital or virtually. This is followed by two additional sessions with a therapist in the municipality, focusing on progression in the exercise program. Participants will receive written instructions (a Supervised Exercise workbook) along with a personal login to access a patient information video. The exercise program is a highly structured system of hand and upper limb exercises. The program will enable participants to progress their exercises after the initial set-up session with the therapist. The program will utilize a range of resistance exercises based upon functional movements designed to promote recovery of the strength required for activities of daily living (e.g., chopping, lifting, pushing, jar opening).

  • OtherUsual Care

    Verbal advice and a leaflet provided at the hospital. Advice will include hand and wrist mobilization exercises to restore flexibility and guidance on building up activity gradually. Participants receiving solely usual care will not be provided with access to the intervention materials (the Supervised Exercise workbook).

06

What researchers measure

Primary outcomes

  1. Patient-Rated Wrist Evaluation (PRWE)

    The primary outcome is the Patient Rated Wrist Evaluation (PRWE) at 6 months post-randomization: A 15 item patient-reported questionnaire that assesses pain and functional difficulties in activities of daily living resulting from injuries affecting wrist joint area (total score ranges from 0 to 100, higher scores indicate worse wrist pain and function). The pain subscale has 5 items (0 = no pain, 10 = worst pain) and the function subscale has 10 items (0 = no difficulty, 10 = unable to do). A total score on a scale of 100 is computed from the two subscales equally weighted (0 = no disability). The total score is the trial primary outcome, with the two subscales also reported as secondary outcomes.

    Time frame: Measured at baseline, 3 months and 6 months follow-up

Secondary outcomes

  1. Wrist pain subscale measured using the Patient Rated Wrist Evaluation (PRWE)

    The PRWE pain subscale contains 5 items each of which is further rated from 0-10 (0 = no pain, 10 = worst pain). The maximum score in this section is 50 and minimum 0.

    Time frame: Baseline, 3 months and 6 months follow-up

  2. Wrist function subscale measured using the Patient Rated Wrist Evaluation (PRWE)

    The PRWE function subscale contains 10 items which are further divided into 2 sections i.e specific activities (having 6 items) and usual activities (having 4 items) and is rated from 0-10 (0 = no difficulty, 10 = unable to do). The score of all 10 items is summed and then divided by 2, resulting in a maximum score of 50 and minimum 0.

    Time frame: Baseline, 3 months and 6 months follow-up

  3. PROMIS Physical Function Upper Extremity-Short Form 7a

    Self-reported capability focusing on activities that require use of the upper extremity including shoulder, arm, and hand activities. The PROMIS Physical Function Upper Extremity-Short Form 7a contains 7 questions scored 1-5, with 1 being unable to do the activity and 5 being able to do the activity without any difficulty.

    Time frame: Baseline, 3 months and 6 months follow-up

  4. QuickDASH

    The QuickDASH is a shortened version of the DASH Outcome Measure. Instead of 30 items, the QuickDASH uses 11 items to measure physical function and symptoms in people with any or multiple musculoskeletal disorders of the upper limb. The QuickDASH is scored in two components: the disability/symptom section (11 items, scored 1-5) and the optional high performance sport/music or work modules (four items, scored 1-5). A higher score indicates greater disability.

    Time frame: Baseline, 3 months and 6 months follow-up

  5. EuroQol 5 Dimensions (EQ-5D-5L)

    Quality of life measured using the EuroQol 5 Dimensions (EQ-5D-5L) a validated, generalized and standardized instrument comprising a Visual Analogue Scale (VAS) measuring self-rated health and a health status instrument, consisting of a five-level response (no problems, some problems, moderate problems, severe problems and unable) for five domains related to daily activities; (i) mobility, (ii) selfcare, (iii) usual activities, (iv) pain and discomfort and (v) anxiety and depression. Responses to the health status classification system are converted into an overall score using a published utility algorithm for the Danish population. The EQ-5D health status scale ranges from negative scores -0.594 \[reflective of a patient's quality of life being worse than death\], 0 \[death\], to 1 \[perfect health\]. A respondent's EQ-VAS gives self-rated health on a scale where the endpoints are labelled 'best imaginable health state' (100) and 'worst imaginable health state' (0).

    Time frame: Baseline, 3 months and 6 months follow-up

  6. Self-Efficacy for Exercise scale (SEE)

    A 9-item participant-reported questionnaire (total scores range from 0 to 90, higher scores indicate higher self-efficacy for exercise) will be used to assess the participants' confidence in their ability to exercise

    Time frame: Baseline, 3 months and 6 months follow-up

  7. Exercise adherence measured by self-reported exercise frequency

    Participants will be asked to indicate how many times in the preceding week they have done specific exercises for their injured hand and upper extremity, to assess engagement with the advised exercises after wrist fracture.

    Time frame: 3 months and 6 months follow-up

  8. Serious adverse events (SAEs)

    All unexpected serious adverse events related to the randomized interventions will be recorded. These events will be reported by recruitment centers as they become aware of events. Serious adverse events are an adverse event that: results in death; is life-threatening, requires hospitalisation or prolongation of existing hospitalisation; results in persistent or significant disability or incapac-ity; is a congenital anomaly or birth defect; or is otherwise considered medically significant by the in-vestigator (i.e., medical events that may jeopardise the participant or may require an intervention to pre-vent one of the above characteristics/consequences).

    Time frame: 3 months and 6 months follow-up

  9. Adverse events (AEs)

    Foreseeable adverse events will be recorded as complications both by recruitment centers and participants. AEs that are unrelated to the intervention will not be reported. AEs deemed related to the intervention that do not meet the SAE definition and are not classed as foreseeable as per the following (such as discomfort during performance of exercises), will also not be reported. Foreseeable adverse events include: increase in pain lasting more than one week; treatment-related exacerbations of other medical conditions that do not meet the definition of serious (for example angina after exertion); development of Complex Regional Pain Syndrome; surgery to the injured wrist (unless an adverse event directly related to the exercise intervention, in which case this would be an SAE); development of carpal tunnel syndrome requiring medical intervention (corticosteroid injection or surgery); wound complication in the injured wrist.

    Time frame: 3 months and 6 months follow-up

Other outcomes

  1. Health resource use

    Health resource use as measured by self-reported bespoke questionnaire (including primary and secondary care consultation, additional therapy, investigations, surgery, prescribed and over-the-counter pain medication), sick leave (days), out-of-pocket expenses. Resource use will be converted into costs using standard unit cost estimates. The components will be aggregated to estimate the total cost per participant.

    Time frame: 3 months and 6 months follow-up

07

Study locations

1 of 1 sites recruiting
08

References and documents

Study documents

  • Statistical analysis plan · Jun 17, 2026

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Yes — Anonymized patient-level data will be shared with collaborators in the UK to be combined in an individual participant data meta-analysis. Anonymized patient-level data will also be made available if required by the scientific journal, in which the results of the trial are published. Additionally, researchers presenting a justified cause for receiving the data can obtain it after a data access agreement has been signed.

Supporting information: Study protocol, Sap, Icf, Analytic code

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 30, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07538323
Lead sponsor
University of Aarhus
Collaborators
Aarhus University Hospital Skejby
Responsible party
Sponsor
First posted
Apr 20, 2026
Start date
May 12, 2026
Primary completion
Dec 2029 (estimated)
Completion
Dec 2029 (estimated)
Last update
Jun 30, 2026

Study contacts

Inger Mechlenburg, DMSc
Contact
inger.mechlenburg@clin.au.dk
+45 21679062
Andreas Bentzen, MHSc
Contact
andreas.bentzen@clin.au.dk
+45 53109112
Inger Mechlenburg, DMSc
principal investigator · Aarhus University Hospital
Jan D. Rölfing, MD.
study chair · Aarhus University Hospital
Per H. Gundtoft, MD.
study chair · Aarhus University Hospital
Andreas Bentzen, MHSc
study chair · Aarhus University Hospital
David J. Keene, PhD
study chair · University of Oxford
Matthew Costa, MD, PhD
study chair · University of Oxford

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion